Evidence map›Paper›PMID 41811907›Full record

ArticlePLoS computational biology2026

MultiPert: An adversarial alignment and dual attention framework for single-cell multi-omics perturbation prediction.

Mengyuan Zhao, Xinyue Tang, Jiawei Li, Cheng Liang, Jijun Tang, Fei Guo

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mengyuan ZhaoShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Xinyue TangShenzhen University of Advanced Technology, Shenzhen, China.
Jiawei LiCollege of Intelligence and Computing, Tianjin University, Tianjin, China.
Cheng LiangShandong Normal University, Jinan, China.
Jijun TangUniversity of Chinese Academy of Sciences, Beijing, China.
Fei GuoSchool of Computer Science and Engineering, Central South University, Changsha, China.ORCID https://orcid.org/0000-0001-8346-0798

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise prediction of perturbation responses is essential in systems biology research, as it plays a pivotal role in characterizing cellular identities and elucidating the regulatory mechanisms of biological pathways. Existing perturbation-responses prediction approaches are predominantly confined to single-modality transcriptomic data, limiting their capacity to capture cross-layer molecular effects. Here, we present MultiPert, a deep learning framework specifically designed for predicting perturbation responses in single-cell multi-omics data. MultiPert employs modality-specific encoders with dedicated pretraining, integrates perturbation through a dual-attention mechanism, and achieves cross-modal alignment via adversarial training. Benchmarking on human THP-1 and kidney multi-omics datasets demonstrates that MultiPert reliably predicts both perturbed gene expression and protein abundance profiles, achieving superior accuracy and stability compared to state-of-the-art strategies. MultiPert generalizes to unseen perturbations and uncovers regulatory mechanisms of immune checkpoint molecules based on perturbed proteomic predictions. In addition, enrichment analyses of perturbed transcriptomic predictions reveal immune-related pathways. By providing an integrated and interpretable framework, MultiPert expands the scope of perturbation modeling at the multi-omics level, thereby offering a robust methodological foundation for comprehensive research into pathogenesis and drug discovery.

Indexed as

Computational BiologyDeep LearningSingle-Cell AnalysisAlgorithmsGene Expression ProfilingHumansMultiomicsProteomicsSystems BiologyTranscriptome

Identifiers

PMID41811907
PMCPMC12998955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.